An Overview of the Minor Cannabinoid CBCv

Cannabichromevarin (CBCv) was first discovered in 1975 by researchers from the University of Nagasaki who isolated the cannabinoid from the cannabis plant. However, after CBCv’s discovery, there was not much research done about it, but because of its similar molecular structure to CBC, it can be assumed that is shares some similar benefits.

CBCv is one of several minor cannabinoids found in cannabis sativa and is present in both marijuana and hemp strains of the plant. But if CBCv holds similar benefits to CBC, there could be an array of conditions and diseases that could be improved with CBCv. CBC is known for being an antidepressant and could potentially bring relief to individuals struggling with this disorder.

Being an anti-inflammatory, it may potentially help individuals who have chronic inflammation and pain. CBC has also been found to be antifungal and antibiotic, which could end up being an all-natural alternative medicine for fungal issues like athlete’s foot and ringworm. And because it has antibiotic properties, it may help fight against certain resistant bacteria within the human body.

One thing we do know about the compound is that it has the potential to be a powerful anticonvulsant. This alone makes it worthy of further investigation.

When it comes to CBCv, there is still plenty of research to be done about this cannabinoid. Researchers from the Regents of the University of California have found it important enough to patent an anticonvulsant drug for infants in which CBCv is mentioned as a potential ingredient. Going forward, scientists will no doubt be looking deeper into the properties of this mysterious cannabinoid. From what it looks like, CBCv has all the possibilities of being a life-changing cannabinoid.

By Andrea, published on